Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo.
about
Nmp4/CIZ suppresses parathyroid hormone-induced increases in trabecular bone.ClC-3 chloride channel mediates the role of parathyroid hormone [1-34] on osteogenic differentiation of osteoblastsThe serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation.Insulin like growth factor-I: a critical mediator of the skeletal response to parathyroid hormoneIdentification of transcriptional factors and key genes in primary osteoporosis by DNA microarray.Targeting Runx2 expression in hypertrophic chondrocytes impairs endochondral ossification during early skeletal developmentRunx2-interacting genes identified by yeast two-hybrid screening of libraries generated from hypertrophic chondrocytes.Yap/Taz transcriptional activity in endothelial cells promotes intramembranous ossification via the BMP pathway.Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts.PTH and PTHrP signaling in osteoblastsZfp521 antagonizes Runx2, delays osteoblast differentiation in vitro, and promotes bone formation in vivo.Inducible expression of Runx2 results in multiorgan abnormalities in mice.miR-96 promotes osteogenic differentiation by suppressing HBEGF-EGFR signaling in osteoblastic cells.Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling.Serotonin 2B receptor (5-HT2B R) signals through prostacyclin and PPAR-ß/δ in osteoblastsEffects of risedronate in Runx2 overexpressing mice, an animal model for evaluation of treatment effects on bone quality and fractures.
P2860
Q33405128-BE812976-A2CF-442A-A44D-AADE1561908FQ33596686-46E2C252-8F65-49D8-8260-3A8E6D197A39Q33617543-D22E6BF9-BBCE-48FA-A781-B867A2FDC6BDQ33970422-7F1EEE4F-169F-4FDD-AB0F-CD6B7B66AD52Q35622274-5BAF1ACC-D1A3-4F33-9A5E-D403B6A6227FQ35985042-E32528A3-BE10-45C0-8837-4D8FFFF30FE3Q36246941-6B8C3087-D25B-4D19-A7A0-F5C285416453Q36974752-5CDAB61F-4135-42F8-A587-1EB7E28D17D2Q37164557-E634269E-51D9-4633-BA91-EF64A1B4FCC6Q37297529-1DEBA1F7-4E2C-4CCF-9AAF-CBC44D51AF2DQ37351658-5BAF38AC-EE0F-4AFD-8FE8-E5BD2297D0FAQ37365273-2E35B5D0-3275-40DD-B1EB-FF697B6392B1Q38934605-68A3C043-3888-4296-90DE-BA5624F5C8D0Q41874349-C69ABCCC-1BAF-46E6-B8CC-6966F041DFD7Q42629276-E79CF16C-5420-488C-9286-F4BE57A52563Q51482952-4EB9C037-57B0-40F5-B593-F124A298332F
P2860
Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Overexpression of the transcri ...... f parathyroid hormone in vivo.
@ast
Overexpression of the transcri ...... f parathyroid hormone in vivo.
@en
type
label
Overexpression of the transcri ...... f parathyroid hormone in vivo.
@ast
Overexpression of the transcri ...... f parathyroid hormone in vivo.
@en
prefLabel
Overexpression of the transcri ...... f parathyroid hormone in vivo.
@ast
Overexpression of the transcri ...... f parathyroid hormone in vivo.
@en
P2093
P2860
P1476
Overexpression of the transcri ...... f parathyroid hormone in vivo.
@en
P2093
Caroline Marty
Didier Merciris
Marie-Christine de Vernejoul
P2860
P304
P356
10.2353/AJPATH.2007.061069
P407
P577
2007-05-01T00:00:00Z